Array Biopharma (ARRY) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $8.56 +7.00%
EPS Growth %: -48.0%
Financial Fact:
Interest income: 70K
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -48.0%
Financial Fact:
Interest income: 70K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q1 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $6.07 million versus the consensus estimate of $6.35 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Worried the AI trade has gone too far? Evercore likes these 4 stocks
- Playboy to buy back 16.6M shares from Fortress at $1.05 each
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
